Mental Wellness Program

Bio-Escitalopram escitalopram

Evaluated tools to help you understand your treatment, track what changes and know who to talk to.

Selective serotonin reuptake inhibitor (SSRI) · ATC N06AB10

These tools apply to every medication containing escitalopram, whatever the manufacturer.

Where are you in your treatment?

Essentials to get started

Tools by topic

Understand your treatment

How escitalopram works, and what to expect.

Take care of yourself day to day

Therapy, stress management and support, at your own pace.

  • Website

    Relief — self-management workshops

    10- to 12-week group workshops, online or in person in several Quebec regions, to live better with anxiety, depression or bipolar disorder.

    ReliefFree

  • Website

    Bounce Back

    Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.

    Canadian Mental Health Association (CMHA) – Quebec DivisionFree

  • Video

    Building connections and being well surrounded

    Why social connections protect mental health, with practical ideas to build and keep them.

    Mouvement Santé mentale QuébecFree

  • App

    Prezens

    Short breathing, meditation and mindfulness exercises to pause and find calm.

    Emergence asblFree

  • App

    MindDay

    Daily online coaching based on recognized strategies and mindfulness, to better understand thoughts and emotions.

    mindDay SASPaid or limited trial

  • Website

    Équilia — CBT and mindfulness program

    Free, self-paced 6-lesson online program combining cognitive behavioural therapy and mindfulness. No waiting list.

    Équilia research team (CIHR project, Quebec–Ontario collaboration)Free

Track what changes

Note how you feel to see how things evolve, and bring it to your appointments.

  • App

    Daylio

    Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.

    Relaxio s.r.o.Limited free version

  • Website

    MesOutils.ca

    Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.

    Association québécoise de prévention du suicide (AQPS) / CETI-SMDIFree

Know when to call

What is expected, what should make you call, and who to contact.

  • Article

    Understanding antidepressant medications, part 1: how to use them safely

    What antidepressants do, how long they take to work, and which side effects are common at the start.

    Canadian Medication Appropriateness and Deprescribing Network (CADeN)Free

  • Article

    Drugs for treatment of depression

    Consumer reference on antidepressant classes, how they act, and their side effects.

    Merck Manual (Consumer Version)Free

  • Website

    MesOutils.ca

    Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.

    Association québécoise de prévention du suicide (AQPS) / CETI-SMDIFree

Bio-Escitalopram products

DIN Strength Form DPD status Program
02481146 5 mg TABLET Approved, not yet marketed —
02481154 10 mg TABLET Marketed Yes
02481162 15 mg TABLET Approved, not yet marketed —
02481170 20 mg TABLET Marketed Yes

Other escitalopram DINs on the market 75

75 products from other manufacturers. If your DIN is in this list, the tools on this page apply to you too.

DIN BrandManufacturer Strength Form DPD status
02434652 ACH-ESCITALOPRAMACCORD HEALTHCARE INC 10 mg TABLET Marketed
02434660 ACH-ESCITALOPRAMACCORD HEALTHCARE INC 20 mg TABLET Marketed
02477734 AG-ESCITALOPRAMANGITA PHARMA INC. 5 mg TABLET Approved, not yet marketed
02477742 AG-ESCITALOPRAMANGITA PHARMA INC. 10 mg TABLET Marketed
02510944 AG-ESCITALOPRAM TABLETSANGITA PHARMA INC. 10 mg TABLET Marketed
02477750 AG-ESCITALOPRAMANGITA PHARMA INC. 15 mg TABLET Approved, not yet marketed
02477769 AG-ESCITALOPRAMANGITA PHARMA INC. 20 mg TABLET Marketed
02510952 AG-ESCITALOPRAM TABLETSANGITA PHARMA INC. 20 mg TABLET Marketed
02295016 APO-ESCITALOPRAMAPOTEX INC 10 mg TABLET Marketed
02295024 APO-ESCITALOPRAMAPOTEX INC 20 mg TABLET Marketed
02397331 AURO-ESCITALOPRAMAURO PHARMA INC 5 mg TABLET Approved, not yet marketed
02397358 AURO-ESCITALOPRAMAURO PHARMA INC 10 mg TABLET Marketed
02397366 AURO-ESCITALOPRAMAURO PHARMA INC 15 mg TABLET Approved, not yet marketed
02397374 AURO-ESCITALOPRAMAURO PHARMA INC 20 mg TABLET Marketed
02477203 ESCITALOPRAMJAMP PHARMA CORPORATION 5 mg TABLET Approved, not yet marketed
02429780 ESCITALOPRAMJAMP PHARMA CORPORATION 10 mg TABLET Marketed
02508893 JAMP ESCITALOPRAMJAMP PHARMA CORPORATION 10 mg TABLET Marketed
02477181 ESCITALOPRAMJAMP PHARMA CORPORATION 15 mg TABLET Approved, not yet marketed
02429799 ESCITALOPRAMJAMP PHARMA CORPORATION 20 mg TABLET Marketed
02508907 JAMP ESCITALOPRAMJAMP PHARMA CORPORATION 20 mg TABLET Marketed
02466058 ESCITALOPRAMJUBILANT GENERICS LIMITED 10 mg TABLET Approved, not yet marketed
02466066 ESCITALOPRAMJUBILANT GENERICS LIMITED 20 mg TABLET Approved, not yet marketed
02512653 KYE-ESCITALOPRAMKYE PHARMACEUTICALS INC. 15 mg TABLET Marketed
02537400 RIVA-ESCITALOPRAMLABORATOIRE RIVA INC. 5 mg TABLET Approved, not yet marketed
02428830 RIVA-ESCITALOPRAMLABORATOIRE RIVA INC. 10 mg TABLET Dormant (not currently sold)
02537419 RIVA-ESCITALOPRAMLABORATOIRE RIVA INC. 15 mg TABLET Approved, not yet marketed
02428857 RIVA-ESCITALOPRAMLABORATOIRE RIVA INC. 20 mg TABLET Dormant (not currently sold)
02263211 CIPRALEX -5MGLUNDBECK CANADA INC 5 mg TABLET Approved, not yet marketed
02263238 CIPRALEX -10MGLUNDBECK CANADA INC 10 mg TABLET Marketed
02263246 CIPRALEX -15MGLUNDBECK CANADA INC 15 mg TABLET Approved, not yet marketed
02263254 CIPRALEX -20MGLUNDBECK CANADA INC 20 mg TABLET Marketed
02566885 M-ESCITALOPRAMMANTRA PHARMA INC 5 mg TABLET Approved, not yet marketed
02471418 M-ESCITALOPRAMMANTRA PHARMA INC 10 mg TABLET Marketed
02566893 M-ESCITALOPRAMMANTRA PHARMA INC 15 mg TABLET Approved, not yet marketed
02471426 M-ESCITALOPRAMMANTRA PHARMA INC 20 mg TABLET Marketed
02421879 IPG-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 5 mg TABLET Approved, not yet marketed
02423472 MAR-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 5 mg TABLET Approved, not yet marketed
02421887 IPG-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 10 mg TABLET Approved, not yet marketed
02423480 MAR-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 10 mg TABLET Marketed
02421895 IPG-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 15 mg TABLET Approved, not yet marketed
02423499 MAR-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 15 mg TABLET Approved, not yet marketed
02421909 IPG-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 20 mg TABLET Approved, not yet marketed
02423502 MAR-ESCITALOPRAMMARCAN PHARMACEUTICALS INC 20 mg TABLET Marketed
02407418 MINT-ESCITALOPRAMMINT PHARMACEUTICALS INC 10 mg TABLET Marketed
02407426 MINT-ESCITALOPRAMMINT PHARMACEUTICALS INC 15 mg TABLET Approved, not yet marketed
02407434 MINT-ESCITALOPRAMMINT PHARMACEUTICALS INC 20 mg TABLET Marketed
02309467 MYLAN-ESCITALOPRAMMYLAN PHARMACEUTICALS ULC 10 mg TABLET Marketed
02309475 MYLAN-ESCITALOPRAMMYLAN PHARMACEUTICALS ULC 20 mg TABLET Marketed
02554895 NATCO-ESCITALOPRAMNATCO PHARMA (CANADA) INC 5 mg TABLET Approved, not yet marketed
02554909 NATCO-ESCITALOPRAMNATCO PHARMA (CANADA) INC 10 mg TABLET Marketed
02554917 NATCO-ESCITALOPRAMNATCO PHARMA (CANADA) INC 15 mg TABLET Approved, not yet marketed
02554933 NATCO-ESCITALOPRAMNATCO PHARMA (CANADA) INC 20 mg TABLET Marketed
02489163 NRA-ESCITALOPRAMNORA PHARMA INC 5 mg TABLET Approved, not yet marketed
02476851 NRA-ESCITALOPRAMNORA PHARMA INC 10 mg TABLET Marketed
02489198 NRA-ESCITALOPRAMNORA PHARMA INC 15 mg TABLET Approved, not yet marketed
02476878 NRA-ESCITALOPRAMNORA PHARMA INC 20 mg TABLET Marketed
02566354 BALANSYAORIMED PHARMA INC 2 mg SOLUTION Marketed
02303949 PMSC-ESCITALOPRAMPHARMASCIENCE INC 10 mg TABLET Dormant (not currently sold)
02469243 PMS-ESCITALOPRAMPHARMASCIENCE INC 10 mg TABLET Marketed
02303965 PMSC-ESCITALOPRAMPHARMASCIENCE INC 20 mg TABLET Dormant (not currently sold)
02469251 PMS-ESCITALOPRAMPHARMASCIENCE INC 20 mg TABLET Marketed
02424401 ESCITALOPRAMPRO DOC LIMITEE 10 mg TABLET Marketed
02424428 ESCITALOPRAMPRO DOC LIMITEE 20 mg TABLET Marketed
02364077 SANDOZ ESCITALOPRAMSANDOZ CANADA INCORPORATED 10 mg TABLET Marketed
02364085 SANDOZ ESCITALOPRAMSANDOZ CANADA INCORPORATED 20 mg TABLET Marketed
02430118 ESCITALOPRAMSANIS HEALTH INC 10 mg TABLET Marketed
02430126 ESCITALOPRAMSANIS HEALTH INC 20 mg TABLET Marketed
02429039 ESCITALOPRAMSIVEM PHARMACEUTICALS ULC 10 mg TABLET Marketed
02429047 ESCITALOPRAMSIVEM PHARMACEUTICALS ULC 20 mg TABLET Marketed
02385481 SPC-ESCITALOPRAMSUN PHARMA CANADA INC 10 mg TABLET Marketed
02385503 SPC-ESCITALOPRAMSUN PHARMA CANADA INC 20 mg TABLET Marketed
02318180 TEVA-ESCITALOPRAMTEVA CANADA LIMITED 10 mg TABLET Marketed
02454297 ACT ESCITALOPRAM ODTTEVA CANADA LIMITED 10 mg TABLET (ORALLY-DISINTEGRATING) Marketed
02318202 TEVA-ESCITALOPRAMTEVA CANADA LIMITED 20 mg TABLET Marketed
02454300 ACT ESCITALOPRAM ODTTEVA CANADA LIMITED 20 mg TABLET (ORALLY-DISINTEGRATING) Marketed

For pharmacists and healthcare professionals

Every tool was evaluated against public criteria. You can share this page directly with your patients: no DIN is required.